BioCentury
ARTICLE | Clinical News

Sofosbuvir/velpatasvir/GS-9857: Phase II data

May 9, 2016 7:00 AM UTC

Top-line data from the open-label, U.S. Phase II TRILOGY-3 trial in 49 DAA-experienced patients with chronic HCV genotype 1 infection with or without cirrhosis showed that once-daily 400/100/100 mg or...